Chapter 114 - The Federal Gauntlet in Wilmington

The morning sun broke through the autumn clouds, casting a harsh, glaring light across the gray limestone facade of the J. Caleb Boggs Federal Building in Wilmington, Delaware. The courthouse steps were barricaded with steel crowd barriers, swarming with international business reporters, satellite broadcasting trucks from CNBC and Reuters, and hundreds of pediatric healthcare advocates carrying banners that read: Save the Hope Valve! Children over Greed!
At precisely eight-fifteen, a convoy of three black armored Suburbans pulled up to the curb.
Cameras flashed in a deafening barrage as Julian Vance stepped out, escorting his mother Grace and Aunt Lily. Behind them stepped Dr. Hope Vance, flanked by Dr. Clara Vance Patel and Marcus Vance Jr. They walked up the courthouse steps in synchronized, royal rhythm, their expressions calm, dignified, and terrifyingly serene. Hope wore a tailored dark navy suit with her grandmother Emily’s diamond-and-sapphire pin gleaming on her lapel. She looked directly into the news cameras, offering no frantic statements, only the silent, diamond-hard confidence of absolute truth.
Ten minutes later, Damian Cross arrived in a chauffeured Maybach. Flanked by six private bodyguards and his defense lawyers, Damian walked swiftly past the media shouting questions, his chin tilted high in practiced disdain, holding a heavy, locked leather attache case.
Inside Courtroom 4A, the tension was suffocating. The gallery was packed with hospital executives, patent examiners, and Wall Street short-sellers who had wagered hundreds of millions on Aethelgard’s lawsuit.
Chief Judge Evelyn Harrison took the bench at nine o'clock sharp. Her silver hair was pulled back into a severe bun, her hazel eyes scanning the counsel tables with unsparing judicial authority.
"We are here on an emergency motion for a preliminary injunction filed by Aethelgard Bio-Capital against the Hawthorne-Vance Generational Trust and Hawthorne Bio-Therapeutics," Judge Harrison began, her voice cutting through the silent room like a scalpel. "The court has reviewed the initial briefs. Mr. Burke, you have ten minutes to present your foundation before I hear from the defense."
Harrison Burke stood up, adjusting his thousand-dollar tie. "May it please the court. For four decades, the Hawthorne family has operated under an unassailable halo of public charity. But philanthropy cannot erase legal reality. In our custody is Plaintiff’s Exhibit A: the primary research diary of Dr. Sebastian Cross, dated September 1993, while he was employed under an auxiliary research grant funded by Carter Financial."
Burke signaled to Damian Cross, who unlocked the leather attache case and produced a faded, leather-bound notebook with yellowed pages.
"In this diary," Burke declared dramatically, holding it aloft for the courtroom to see, "Dr. Cross documented the isolation of a novel embryonic peptide scaffold extracted from placental tissue delivered at Oakridge Memorial. That exact peptide structure forms the core of the Hope Valve Mark VI. Under commercial trade secret covenants, all intellectual property generated under Carter Financial research grants belongs to the corporate successor entity—which my client acquired through legal asset dissolution. We ask this court to impound all Mark VI production lots until our sixty-percent equity ownership is established."
Judge Harrison looked down from the bench, her expression unreadable. "Mr. Vance, does the defense wish to cross-examine?"
Marcus Vance Jr. rose with majestic ease. "Your Honor, we do not merely wish to cross-examine. We move for immediate forensic authentication of Plaintiff’s Exhibit A under Federal Rule of Evidence 901. And to perform that authentication, we call our first expert witness: Dr. Clara Vance Patel."
A murmur swept through the courtroom. Damian Cross sneered, whispering to his lawyer that a thirty-four-year-old resident surgeon was no forensic chemist.
Clara took the witness stand, taking the oath with a clear, resonant voice that echoed her mother Hope's tone. She placed a portable spectral analysis terminal onto the witness desk.
"Dr. Patel," Marcus began. "You have reviewed the digitized scans of Dr. Sebastian Cross's 1993 diary submitted by the plaintiff. Have you conducted a molecular analysis of the specific peptide sequence documented on page forty-eight?"
"I have," Clara replied, looking directly at the judge. "The peptide sequence that Mr. Burke claims was discovered by Dr. Sebastian Cross in September 1993 contains three synthetic amino-acid bridges: Alpha-Fluoro-Proline, Norleucine-6, and Beta-Cyclohexylalanine."
Clara paused, her clear brown eyes turning slowly toward Damian Cross.
"Those three synthetic amino acids were first developed by the Max Planck Institute in Germany in the year 2019," Clara stated calmly, her voice echoing in the dead-silent courtroom. "They did not exist in nature, in clinical medicine, or in organic chemistry in September 1993. It is chemically, biologically, and historically impossible for anyone to have written that sequence forty-two years ago."
Gasps erupted across the gallery. Judge Harrison’s eyebrows dropped into a terrifying, lethal line.
"Furthermore, Your Honor," Clara continued smoothly, "our team subjected the scanned ink profile to high-performance liquid chromatography. The ink used on those yellowed pages is an oil-based pigment manufactured by the Pelikan Corporation—specifically, an ink formulation containing a proprietary UV stabilizer that Pelikan did not introduce to the global market until November 2021."
May you like
Harrison Burke’s face went completely white. He dropped his pen onto the table, his hands trembling violently.
"Mr. Burke," Judge Harrison’s voice was pure ice. "Did your client manufacture this document?"